Tag Archives: EGFR

Are liquid biopsies a surrogate for tissue EGFR testing?


Molecular profiling has changed the treatment landscape in advanced non-small-cell lung cancer. Accurately identifying the tumours that harbour sensitizing EGFR mutations, the most common targetable molecular alteration, as well as those with acquired resistance mutations (e.g. T790M) on treatment is ...

Read More »